Yellow Fever Vaccine in Patients With Rheumatic Diseases
Last updated on July 2021Recruitment
- Recruitment Status
- Completed
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Granulomatosis With Polyangiitis
- Inflammatory Myopathy
- Juvenile Dermatomyositis
- Juvenile Idiopathic Arthritis
- Mixed Connective Tissue Disease
- Rheumatoid Arthritis
- Sjogren's Syndrome
- Spondyloarthritis
- Systemic Lupus
- Systemic Sclerosis
- Takayasu Arteritis
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: Non-RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Prevention
Participation Requirements
- Age
- Between 2 years and 60 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03430388
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Eloisa Bonfa, MD, PhD Rheumatology Division of Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, SP - Brazil